CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Genetix Group plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Genetix Group plc
Queensway New Milton Hampshire
Phone: +44 1425624600p:+44 1425624600 Hampshire, BH25 5NN  United Kingdom Ticker: GTXGTX

This company was Merged or Acquired on 1/11/2010.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Molecular Devices formerly Genetix Group plc, along with its subsidiaries, is engaged in the design, development, manufacture and marketing of automated systems, services and consumables for cell biology, cytogenetics, pathology, proteomic and genomic research worldwide. The biopharmaceutical family of products include the ClonePixFL and associated reagents, which are used to identify the antibody clones that form the basis of pharmaceutical drugs. The ClonePix FL is also used to identify high-yielding cell lines for a customer’s production process. Its Cytovision systems are used worldwide for both pre and post natal genetic testing, and identifying certain forms of cancer, such as leukemia. Its Ariol system is used to image tissue samples from patients. Its wholly owned subsidiaries include Genetix Limited, Genescreen Limited, Genpak Limited, Genetix GmbH and Genetix KK. In April 2009, the Company acquired SlidePath Limited. In January 2010, Danaher Corporation acquired 97% interest in the Company.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/200912/31/2008Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive, Executive Director Charles R.De Rohan 47 9/15/2008 9/15/2008
Finance Director, Executive Director Andrew J.Kellet 40 3/27/2006 3/27/2006
Company Secretary Simon C.Hedger 53
Director Philip B.Whitehead 58 1/14/2010 1/14/2010
Director Ronald M.Peters 47 1/14/2010 1/14/2010

Business Names
Business Name
Applied Imaging Corp.
GTX
SlidePath Limited

General Information
Number of Employees: 181 (As of 12/31/2008)
Outstanding Shares: 72,584,509 (As of 12/23/2009)
Shareholders: 27,755
Stock Exchange: LON
Fax Number: +44 1425624700


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 5, 2021